Qnomx
1 known investors
Qnomx provides AI-powered variant interpretation and clinical report generation software for oncology diagnostic laboratories performing NGS-based cancer diagnostics. The platform automates evidence gathering and report formatting to reduce expert workload while maintaining expert control over final interpretations and clinical sign-off.